Newark, April 18, 2022 (GLOBE NEWSWIRE) — As per the report published by The Brainy Insights, the global point of care coagulation testing devices market is expected to grow from USD 1.6 Billion in 2020 to USD 2.95 Billion by 2030, at a CAGR of 6.3% during the forecast period 2021-2030.
The rapid specific examination of bodily fluids at the bedside is known as point-of-care testing (POCT). The key benefit of point-of-care testing is the speed with which a result can be obtained. Results are usually presented in an easy-to-understand format, although this is not always the case, and results may still need to be safely interpreted by a healthcare professional.
Request a Sample Copy of the Research Report: https://www.thebrainyinsights.com/enquiry/sample-request/12648
For a variety of coagulation tests, point-of-care assays are available. These assays are simple to carry out and offer a shorter turnaround time than laboratory-based tests. POC testing is in high demand because to its portability, ease of use, andconnectivity. POC tests provide immediate coagulation testing results, which are required to control the side effects of anticoagulant medication. In several developed nations, patients can test their prothrombin levels at home. It gives precise and timely results. During the forecast period, this is expected to drive the global point-of-care coagulation testing devices market. Another growing factor is the cost savings associated with using POCCT devices instead of central laboratory testing for home treatment of disorders such as haemophilia. Furthermore, the market’s leading players are developing technologically advanced advancements to encourage individuals to use POCCT Devices in a homecare setting. In addition, due to changing hemostatic balance among people as they age, a considerable increase in the number of senior patients suffering from bleeding problems has been observed. Thus, demand for portable and simple-to-use testing devices is growing.
Key players operating in the global point of care coagulation testing devices market are Abbott Laboratories, F. Hoffmann-La Roche AG, Haemonetics Corporation, HemoSonics, Koninklijke Philips N.V., LLC, Medtronic plc, Micropoint …